SOPHiA GENETICS SA (SOPH) provides cloud-based data analytics platforms that help hospitals and researchers interpret genomic and clinical data. Its technology supports cancer diagnostics, precision medicine, and personalized treatment decisions. The company grows by expanding partnerships with healthcare systems, increasing data adoption, and benefiting from rising demand for AI-driven insights in genomics.

On the chart, SOPH printed a confirmation bar with increasing volume as price moved above the .236 Fibonacci level and into the momentum zone. A trailing stop can be established using Fibonacci levels on the Fibonacci snap tool, helping manage risk while allowing momentum to continue.